Operation Warp Speed: Accelerated COVID-19 Vaccine Development Status and Efforts to Address Manufacturing Challenges
Operation Warp Speed was a federal effort that supported multiple COVID-19 vaccine candidates to speed up development. We analyzed the program's vaccine candidates and found that their development followed traditional practices, with some adaptations. For example, some clinical trial phases overlapped with each other and with animal studies to accelerate development. Two vaccines were authorized for emergency use—our tracker shows all the candidates. We also found that agencies are working to help mitigate vaccine manufacturing challenges. For example, agencies have taken steps to require contractors to prioritize vaccine production supplies.
Short title:
Operation Warp Speed: Accelerated COVID-19 Vaccine Development Status and Efforts to Address Manufacturing Challenges
Start date:
2021-02
End date:
2021-02
Homepage:
https://www.gao.gov/products/gao-21-319
Project leader:
Science, Technology Assessment, and Analytics team of the U.S. Government Accountability Office (GAO) (STAA)
Country:
United States of America
Publications:

 Back